What to Know About Methotrexate for Rheumatoid Arthritis

9 Things to Know About Methotrexate for Rheumatoid Arthritis

One of the oldest medicines for rheumatoid arthritis remains a cornerstone for treating the disease.
9 Things to Know About Methotrexate for Rheumatoid Arthritis
Getty Images
Methotrexate is one of the oldest and most cost-effective medicines available for rheumatoid arthritis (RA). It’s also one of the most commonly used RA therapies.

Here’s what to know about this drug if you have RA.

1. Methotrexate Is a First-Line Treatment for RA

Methotrexate falls into the category of disease-modifying antirheumatic drugs, or DMARDs. These drugs do more than deal with symptoms; they actually slow down progression of the disease.

About 60 percent of people with RA are currently on or have been on methotrexate, according to Johns Hopkins Arthritis Center.

In addition to being an effective treatment, methotrexate works relatively quickly and has a milder side-effect profile than other medicines used for RA, says Andrew Tenpas, PharmD, a clinical assistant professor of pharmacy practice at Texas A&M University in Kingsville, Texas.

“We have so much experience with methotrexate, and we know it’s effective and safe,” says Bahar Moghaddam, MD, a rheumatologist at Mount Sinai Hospital in New York City.

2. Methotrexate Fights Inflammation

RA is an inflammatory form of arthritis. Methotrexate is thought to work by causing cells to release a molecule called adenosine that blocks chemicals that promote inflammation.

 Reducing inflammation helps prevent pain and joint damage otherwise experienced by people with the disease.
Scientists realized early on that the drug, initially used to treat cancer, could be useful for RA. By the 1980s, well-designed gold-standard studies began to confirm its value for this condition.

Initially, as with many medicines for RA, methotrexate was primarily given late in the course of the disease, when damage to joints was already done. In 2010, the American College of Rheumatology, along with its European counterparts, revamped their diagnostic criteria for the disease so that people could be diagnosed earlier. Their aim was to “refocus attention on the important need for earlier diagnosis and institution of effective disease-suppressing therapy,” the scientists wrote.

3. Your Doctor Will Determine Your Dose

Most people with RA begin with a 7.5 milligram (mg) dose of methotrexate tablets taken once a week. Over time, if that is not enough to help, your doctor will increase your dosage, perhaps up to 20 mg. The pills are 2.5 mg each, and the usual dose is 3 to 10 pills.

According to the Arthritis Foundation, most people take a weekly dose between 10 and 25 mg for inflammatory arthritis.

“It is extremely important to understand that the drug is taken once weekly, not once each day,” Dr. Tenpas says, noting that mistaking this dosage has led to toxicity in some patients.

Methotrexate can also be given by weekly injection. People can give the methotrexate shot to themselves using an auto-injector. Taking the drug this way allows more of it to get into your system without increasing unwanted side effects.

Dosages for the injected drug are generally similar as for the oral version. The injection is available in 25 mg/ml or 50 mg/2ml vials. The usual dose is 7.5 mg to 25 mg per week.

4. Methotrexate Doesn’t Provide Immediate Relief

Because methotrexate doesn’t simply suppress pain symptoms, it may take a while for people to see whether the drug is effective.

You may see improvement in symptoms three to six weeks after starting the drug, but full benefits can take even longer — up to 12 weeks, according to the American College of Rheumatology.

For many people, methotrexate alone, once it starts workin, is enough to manage RA symptoms. B

ut if you continue to have symptoms after 12 weeks, speak to your doctor about other treatment options, such as combining methotrexate with other disease-modifying drugs.

5. Methotrexate Has Some Side Effects

As with many drugs, people can experience unpleasant, and in rare cases dangerous, side effects from methotrexate. If you experience anything that concerns you, be sure to speak with your healthcare provider.

Side effects may include:

  • Gastrointestinal Upset This is the most common side effect for people with RA.
  • Mouth Sores Up to a third of people taking methotrexate for RA develop mouth ulcers.

  • Headache and Fatigue Sometimes referred to as “methotrexate fog,” this might occur a day after taking a methotrexate dose.

  • Hair Loss Hair loss or thinning while on methotrexate is slow and is reversed once you stop taking the medication; taking folic acid can also help counteract this effect.
  • Rash
  • Dizziness
Methotrexate may also lower the ability of the immune system to fight infections.

People taking methotrexate should call their physician immediately if they experience more serious side effects. These include seizures, confusion, weakness on one or both sides of the body, blurred vision or sudden loss of sight, and loss of consciousness.

6. You May Be Able to Minimize Those Side Effects

Some side effects from methotrexate result from a drop in folic acid levels in the body. To reduce these effects, doctors generally prescribe folic acid supplements along with the drug.

Many people find taking the oral medicine with food can prevent stomach upset, Tenpas says.

Some experts recommend splitting the dose by taking half in the morning and the other half 12 hours later to ease these gastrointestinal side effects. If that doesn’t help, talk to your doctor about switching from the oral to the injectable version of the drug.

To deal with mouth sores, the Arthritis Foundation suggests using a saltwater rinse or special mouthwash containing a lidocaine pain reliever.

If nausea is an issue, you can request a prescription for anti-nausea medicine.

7. Methotrexate Isn’t for Everyone

Methotrexate is contraindicated for those with certain conditions and diseases, including:

  • Liver disease or cirrhosis
  • Alcohol use disorder
  • Kidney disease
  • Blood disorders
  • HIV/AIDS
  • People undergoing radiation therapy

Pregnancy Concerns

Don’t take methotrexate if you’re pregnant, trying to become pregnant, or if you’re breastfeeding. It can interfere with fetal development, and it can pass into breast milk. The Arthritis Foundation recommends using at least two methods of contraception while you’re on methotrexate and for at least three months after you discontinue using it.

 For men, many experts recommend waiting at least three months after stopping the drug before trying to conceive.

Methotrexate Can Impact Vaccine Effectiveness

Because methotrexate affects the immune system, researchers have found that it can blunt the effectiveness of certain vaccines.

The American College of Rheumatology conditionally recommends delaying the dosing of methotrexate for two weeks after flu and COVID-19 vaccines, if disease activity allows.

Anyone who takes methotrexate should work with their physician to discuss their specific drug regimen at the time of any vaccines.

Interactions With Other Medications

It’s vital that you let your doctor know what other medications you’re taking, including any vitamins or supplements. Don’t take methotrexate while taking antibiotics containing trimethoprim sulfamethoxazole (Bactrim, Sulfatrim).

8. Methotrexate Can Raise the Risk of Liver Disease

The release of adenosine, which is believed to fight inflammation, also causes the buildup of scar tissue in the liver.

Because methotrexate has been associated with liver damage, people with RA frequently worry about how taking the drug will affect this crucial organ.

Fortunately, people who take this drug for RA appear to have a lower risk for this than people who take it for some other conditions.

A study comparing the incidence rate for liver disease among those taking methotrexate for psoriasis, psoriatic arthritis, and RA found those with RA were 1 to 3 times less likely to have this problem.

Still, because of the potential for liver problems, regular alcohol use with methotrexate is not considered safe. “People are encouraged to minimize — if not avoid — alcohol consumption,” Tenpas says.

9. Regular Blood Tests Are Needed for Monitoring

When you’re on methotrexate, routine blood tests will be performed every 4 to 12 weeks to check your liver function and your complete blood count (CBC) because methotrexate can also cause a decrease in blood counts.

Not all of the negative effects of the drug cause noticeable symptoms, which is why routine blood tests are helpful for people taking this medication. Your rheumatologist can make changes to your dose of methotrexate if there is ever a problem.

The Takeaway

  • Methotrexate is a mainstay treatment for rheumatoid arthritis, recognized for its ability to slow disease progression and offer symptom relief when used regularly.
  • Although methotrexate can take a few weeks to show benefits, many people with RA find it helps manage symptoms effectively over time, often in combination with other therapies if needed.
  • Side effects like gastrointestinal issues, mouth sores, and fatigue are common, but these can often be managed by adjustments like taking folic acid, splitting doses, or switching to an injectable form.
  • It is crucial to discuss potential drug interactions and vaccine scheduling with your doctor because methotrexate affects the immune system and can interact with other medications, including some antibiotics.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Methotrexate (Rheumatrex, Trexall, Otrexup, Rasuvo). American College of Rheumatology. February 2025.
  2. Methotrexate Drug Information Sheet. Johns Hopkins Arthritis Center.
  3. Methotrexate: Managing Side Effects. Arthritis Foundation.
  4. Weinblatt ME et al. Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis. The New England Journal of Medicine. March 28, 1985.
  5. Aletaha D et al. 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Annals of the Rheumatic Diseases. 2010.
  6. Understanding Methotrexate. Arthritis Foundation. March 18, 2024.
  7. Methotrexate. MedlinePlus. February 15, 2025.
  8. Bass AR et al. 2022 American College of Rheumatology (ACR) Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care & Research. March 2023.
  9. Gelfand JM et al. Risk of Liver Disease in Patients With Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Receiving Methotrexate: A Population-Based Study. Journal of the American Academy of Dermatology. June 2021.
Sian-Yik-Lim-bio

Sian Yik Lim, MD

Medical Reviewer
Sian Yik Lim, MD, is a board-certified rheumatologist at Hawaii Pacific Health. He is a clinical certified densitometrist, certified by the International Society of Clinical Densitometry. He completed his rheumatology fellowship at Massachusetts General Hospital and was also a research fellow at Harvard Medical School. His research interests include osteoporosis, gout, and septic arthritis. Dr. Lim has published in JAMA, Current Opinions in Rheumatology, Osteoporosis International, Bone, Rheumatology, and Seminars in Arthritis and Rheumatism.

Lim has authored several book chapters, including one titled “What is Osteoporosis” in the book Facing Osteoporosis: A Guide for Patients and their Families. He was also an editor for Pharmacological Interventions for Osteoporosis, a textbook involving collaboration from a team of bone experts from Malaysia, Australia, and the United States.
Meryl Davids Landau

Meryl Davids Landau

Author
Meryl Davids Landau is an award-winning health and science writer and a women's fiction author. Her latest novel is Warrior Won, in which a woman facing serious life challenges must learn to use all of her mindfulness and meditation skills. Meryl's articles have appeared in numerous publications, including National Geographic, the Washington Post, The New York Times, Prevention, Oprah Magazine, Consumer Reports, AARP, and of course many pieces for Everyday Health.